Princeton Global Asset Management LLC Aprea Therapeutics, Inc. Transaction History

Princeton Global Asset Management LLC

  • $397 Million
  • Q1 2024

A detailed history of Princeton Global Asset Management LLC transactions in Aprea Therapeutics, Inc. stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 100 shares of APRE stock, worth $407. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$407
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 20, 2023
BUY
$0.38 - $8.2 $38 - $819
100 New
100 $0

Others Institutions Holding APRE

# of Institutions
3
Shares Held
999
Call Options Held
0
Put Options Held
0
View Full List

About Aprea Therapeutics, Inc.

APRE Quotes by TradingView
  • Ticker APRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...
More about APRE
Track This Portfolio

Track Princeton Global Asset Management LLC Portfolio

Follow Princeton Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Global Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email